Royal Society of Tropical Medicine and Hygiene Meeting, Manson House London, 10 December 1998: Meningococcal meningitis in Africa

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 4, 1999, Pages 341-353

  Greenwood, Brian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; Disease control; Epidemics; History; Inmunization; Meningitis; Neisseria meningitidis

Indexed keywords

MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; BACTERIAL VACCINE;

AFRICA; CONFERENCE PAPER; DISEASE CONTROL; EPIDEMIC; EPIDEMIC MENINGITIS; HUMAN; IMMUNOLOGICAL MEMORY; SUDAN; SYMPOSIUM; ARTICLE; HISTORY; INCIDENCE; SEASON;

AFRICA; BACTERIAL VACCINES; DISEASE OUTBREAKS; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; INCIDENCE; MENINGITIS, MENINGOCOCCAL; SEASONS;

EID: 0033154669     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90106-2     Document Type: Conference Paper

References (102)

1. Artenstein, M. S., Gold, R., Zimmerly, J. G., Wyle, F. A., Schneider, H. & Harkins, C. (1970). Prevention of meningococcal disease by group C polysaccharide vaccine. New England Journal of Medicine, 282, 417-420.
2. Binkin, N. & Band, J. (1982). Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy. Lancet, ii, 315-318.
3. Birks, J. S. (1978). Across the Savannas to Mecca. The Overland Pilgrimage Route from West Africa. London: Hurst and Co.
4. Blair, M. C. (1921). Nigeria, Annual Medical and Sanitary Report, 1919-1921.
5. Blakebrough, I. S. (1979). Epidemiological and laboratory studies of meningococcal infections in Nigeria. PhD thesis. University of Liverpool, UK.
6. Blakebrough, I. S. & Gilles, H. M. (1980). The effect of rifampicin on meningococcal carriage in families in northern Nigeria. Journal of Infection, 2, 137-143.
7. Blakebrough, I. S., Greenwood, B. M., Whittle, H. C., Bradley, A. K. & Gilles, H. M. (1983). Failure of meningococcal vaccination to stop transmission of meningococci in Nigerian schoolboys. Annals of Tropical Medicine and Parasitology, 77, 175-178.
8. Bosmans, E., Vimont-Vicary, P., Andre, F. E., Crooy, P. J., Roelants, P. & Vandepitte, J. (1980). Protective efficacy of a bivalent (A + C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Annales de la Société Belge de Médecine Tropicale, 60, 297-306.
9. Broome, C. V., Rugh, M. A., Yada, A. A., Giat, L., Giat, H., Zeltner, J. M., Sanborn, W. R. & Fraser, D. W. (1983). Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bulletin of the World Health Organization, 61, 325-330.
10. Bryant, J. & Fairman, H. D. (1939). Chemotherapy of cerebrospinal fever in the field. Lancet, i, 923-926.
11. Buncombe, A. (1998). City built on the sands of Time. Guardian, 24 November.
12. Campagne, G., Garber, A., Fabre, P., Carlone, G., Ryall, B., Froeschle, J., Schuchat, A., Boulanger, D., Briantais, P. & Chippaux, J. (1997). Safety and immunogenicity of three doses of a N. meningitidis A/C diphtheria conjugate vaccine in infants in Niger. Abstracts of the 37th Intersciences Conference on Antimicrobial Agents and Chemotherapy, September 1997, Toronto, Abstract G-1:192.
13. Cartwright, K. A. V., Jones, D. M., Smith, A. J., Stuart, J. M., Kaczmarski, E. B. & Palmer, S. R. (1993). Influenza A and meningococcal disease. Lancet, 338, 554-557.
14. Ceesay, S. J., Allen, S. J., Menon, A., Todd, J. E., Cham, K., Carlone, G. M., Turner, S. H., Gheesling, L. L., DeWitt, W., Plikaytis, B. D. & Greenwood, B. M. (1993). Decline in meningococcal antibody levels in African children 5 years after vaccination and lack of an effect of booster immunisation. Journal of Infectious Diseases, 167, 1212-1216.
15. Chalmers, A. J. & O'Farrell, W. R. (1916). Preliminary remarks upon epidemic cerebrospinal meningitis as seen in the Anglo-Egyptian Sudan. Journal of Tropical Medicine and Hygiene, 29, 101-116, 117-129.
16. Cohen, S., McGregor, I. A. & Carrington, S. (1961). Gammaglobulin and acquired immunity to malaria. Nature, 192, 733-737.
17. Cuevas, L. E., Kazembe, P., Mughogho, G. K., Tillotson, G. S. & Hart, C. A. (1995). Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin. Journal of Infectious Diseases, 171, 728-731.
18. Danielson, L. & Mann, E. (1806). A history of a singular and very noted disease, which lately made its appearance in Medfield. Medical and Agricultural Register, 1, 65-69.
19. Davis, L. J. (1931). A bacteriological investigation of epidemic cerebrospinal meningitis in the southern Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 24, 617-622.
20. Denis, F., Rey, J. T., Amadou, A., Saliou, P., Price-David, M., M'Boup, S., Cadoz, M., Diop Mar, I. & Etienne, J. (1982). Emergence of meningococcal meningitis caused by W135 serogroup in Africa. Lancet, ii, 1335-1336.
21. Ensor, H. & Balfour, A. (1904). A case of cerebro-spinal meningitis. Journal of the Royal Army Medical Corps, 3, 667-670.
22. Erwa, H. H., Haseeb, M. A., Idris, A. A., Lapeyssonnie, L., Sanborn, W. R. & Sippel, J. E. (1973). A serogroup A meningococcal polysaccharide vaccine. Studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Bulletin of the World Health Organization, 49, 301-305.
23. Ettori, D., Saliou, P., Renaudet, J. & Stoeckel, Ph. (1977). Le vaccin antiméningococcique polysaccharidique du type A: premiers essais contrôles en Afrique de l'ouest. Médecine Tropicale, 37, 230.
24. Galimand, M., Gerbaud, G., Guibourdenche, M., Rou, J.-Y. & Courvalin, P. (1998). High level chloramphenicol resistance in Neisseria meningitidis. New England Journal of Medicine, 339, 868-874.
25. Ghipponi, L., Darrigol, J., Skalova, R. & Cvjetanovic, B. (1971). Study of bacterial air pollution in an arid region of Africa affected by cerebrospinal meningitis. Bulletin of the World Health Organization, 45, 95-101.
26. Gold, R., Lepow, M. L., Goldschneider, I., Draper, T. L. & Gotschlich, E. C. (1975). Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. Journal of Clinical Investigation, 56, 1536-1547.
27. Gold, R., Lepow, M. L., Goldschneider, I., Draper, T. L. & Gotschlich, E. C. (1979). Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. Journal of Infectious Diseases, 140, 690-697.
28. Gotschlich, E. C., Goldschneider, I. & Artentenstein, M. S. (1969). Human immunity to the meningococcus. IV. Immunogenicity of Group A and Group C meningococcal polysaccharides in human volunteers. Journal of Experimental Medicine, 129, 1367-1384.
29. Granoff, D. M., Gupta, R. K., Belshe, R. B. & Anderson, E. L. (1998). Induction of immunological tolerance in adults by meningococcal C polysaccharide vaccination. Journal of Infectious Diseases, 178, 870-874.
30. Greenwood, B. M. & Wali, S. S. (1980). Control of meningococcal infection in the African meningitis belt by selective vaccination. Lancet, i, 729-732.
31. Greenwood, B. M., Whittle, H. C. & Bryceson, A. D. M. (1973). Allergic complications of meningococcal disease. 11. Immunological investigations. British Medical Journal, ii, 737-740.
32. Greenwood, B. M., Bradley, A. K., Cleland, P. G., Haggie, M. H. K., Hassan-King, M., Lewis, L. S., Macfarlane, J. T., Taqi, A. & Whittle, H. C. (1979a). An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features. Transactions of the Royal Society of Tropical Medicine and Hygiene, 73, 557-562.
33. Greenwood, B. M., Cleland, P. G., Haggie, M. H. K., Lewis, L. S., Macfarlane, J. T., Taqi, A. & Whittle, H. C. (1979b). An epidemic of meningococcal infection at Zaria, Northern Nigeria. 2. The changing clinical pattern. Transactions of the Royal Society of Tropical Medicine and Hygiene, 73, 563-566.
34. Greenwood, A. M., Greenwood, B. M., Bradley, A. K., Ball, P. A. J. & Gilles, H. M. (1981). Enhancement of the immune response to meningococcal polysaccharide vaccine in a malaria endemic area by administration of chloroquine. Annals of Tropical Medicine and Parasitology, 75, 261-263.
35. Greenwood, B. M., Bradley, A. K. & Wall, R. A. (1985). Meningococcal disease and season in sub-saharan Africa. Lancet, ii, 829-830.
36. Greenwood, B. M., Bradley, A. K., Smith, A. W. & Wall, R. A. (1987a). Mortality from meningococcal disease during an epidemic in The Gambia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 536-538.
37. Greenwood, B. M., Greenwood, A. M., Bradley, A. K., Williams, K., Hassan-King, M., Shenton, F. C., Wall, R. A. & Hayes, R. J. (1987b). Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa. Journal of Infection, 14, 167-184.
38. Griffiss, J. M. (1982). Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model. Reviews of Infectious Diseases, 4, 159-172.
39. Haelterman, E., Boelaert, M., Suctcns, C., Blok, L., Henkens, M. & Toole, M. J. (1996). Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. Tropical Medicine and International Health, 1, 385-392.
40. Hassan-King, M. K., Wall, R. A. & Greenwood, B. M. (1988). Meningococcal carriage, meningococcal disease and vaccination. Journal of Infection, 16, 55-59.
41. Horn, A. E. (1908). Report on an investigation of cerebro-spinal fever in the northern territories of the Gold Coast in 1908. Journal of Tropical Medicine and Hygiene, 11, 358-364.
42. Horn, D. W. (1951). The epidemic of cerebro-spinal fever in the northern provinces of Nigeria, 1949-1950. Journal of the Royal Sanitary Institute, 71, 573-589.
43. Jones, D. & Sutcliffe, E. M. (1990). Group A meningococcal disease in England associated with the Haj. Journal of Infection, 21, 21-25.
44. Kabir,M. (1997). The 1996 epidemic of meningococcal disease in Nigeria. Presentation at the third meeting of the International Co-ordinating Group (ICG) on vaccine provision for epidemic meningitis control. World Health Organization, Geneva, 8-9 December 1997.
45. Kilpi, T., Peltola, H., Jauhianen, T. & Kallio, M. J. T. (1995). Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Paediatric Infectious Diseases Journal, 14, 270-278.
46. Kirk, R. (1950). Two epidemics of cerebrospinal meningitis. Sudan Notes and Records, 31, 43-53.
47. Kwara, A., Adegbola, R. A., Corrah, P. T., Weber, M., Achtman, M., Morelli, G., Caugant, D. A. & Greenwood, B. M. (1998). Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Tropical Medicine and International Health, 3, 742-746.
48. Lapeyssonnie, L. (1963). La méningite cérébrospinale en Afrique. Bulletin of the World Health Organization, 28 (supplement), 3-114.
49. Lapeyssonnie, L., Louis, J., Bonnardot, R. & Lefevre, M. (1961). Première note concernant l'activité d'une dose unique de sulfamethoxypyridazine par la voie intramusculaire dans le traitment de la méningite cérébrospinale à meningococques. Médecine Tropicale, 21, 129-133.
50. Leach, A., Twumasi, P. A., Kumah, S., Banya, W. S., Jaffar, S., Forrest, B. D., Granoff, D. M., LiButti, D. E., Carlone, G. M., Pais, L. B., Broome, C. V. & Greenwood, B. M. (1997). Induction of immunological memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. Journal of Infectious Diseases, 175, 200-206.
51. Lewis, L. S. (1979). Prognostic factors in acute meningococcaemia. Archives of Disease in Childhood, 54, 44-48.
52. Lewis, R. F., Dorlencourt, F. & Pinel, J. (1998). Long-acting oily chloramphenicol for meningococcal meningitis. Lancet, 352, 823.
53. Macchiavello, O., Omar, W., El Sayed, M. A. & Rahman, K. A. (1954). Control of cerebro-spinal meningitis epidemics with sulfadimidine and penicillin. Bulletin of the World Health Organization, 10, 1-34.
54. MacLennan, J. M., Decks, J. J., Obaro, S., Williams, D., Carlone, G. M., Moxon, E. R. & Greenwood, B. M. (1998). Meningococcal serogroup C conjugate vaccination in infancy induces persistent immunological memory. In: Abstracts of the 11th International Pathogenic Neisseria Conference, 1-6 November 1998, Nice, France, Nassif, X., Quentin-Millet, M.-J. & Taha, M.-K. (compilers). Paris: Editions E. D. K., p. 151.
55. MacLennan, J., Obaro, S., Decks, J., Williams, D., Pais, L., Carlone, G., Moxon, R. & Greenwood, B. M. (1999). Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. Vaccine, 17, 3088-3095.
56. Manson, P. (1898). Tropical Medicine. A Manual of Diseases of Warm Climates. London: Cassell and Company.
57. Marchiafava, N. & Celli, A. (1884). Sopra i micrococchi della meningite cerebrospinale epidemica. Gazetta degli Ospitali, 8, 59-60.
58. McGahey, K. (1905a). Report on an outbreak of epidemic cerebro-spinal meningitis in Zungeru during February and March 1905. Journal of Tropical Medicine, 8, 210-216.
59. McGahey, K. (1905b). Report of the outbreak of cerebro-spinal meningitis at Yola. Journal of Tropical Medicine, 8, 216-217.
60. McIntyre, P. B., Berkey, C. S., King, S. M., Schaad, U. B., Kilpi, T., Kanra, G. Y. & Perez, C. M. (1997). Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomised clinical trials since 1988. Journal of the American Medical Association, 278, 925-931.
61. Mohammed, I. & Zaruba, K. (1981). Control of epidemic meningococcal meningitis by mass vaccination. Lancet, ii, 80-83.
62. Molineaux, L. (1969). Climate and meningococcal meningitis. PhD thesis, University of Berkeley, USA.
63. Moore, P. S., Harrison, L. H., Telzak, E. E., Ajello, G. W. & Broome, C. V. (1988). Group A meningococcal carriage in travellers returning from Saudi Arabia. Journal of the American Medical Association, 260, 2686-2689.
64. Moore, P. S., Plikaytis, B. D., Bolan, G. A., Oxtoby, M. J., Yada, A., Zougba, A., Reingold, A. L. & Broome, C. V. (1992). Detection of meningitis epidemics in Africa: a population based analysis. International Journal of Epidemiology, 21, 155-162.
65. Morelli, G., Malorny, B., Müller, K., Seiler, A., Wang, J.-F., del Valle, J. & Achtman, M. (1997). Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Molecular Microbiology, 25, 1047-1064.
66. Mpairwe, Y. & Matovu, H. L. (1971). Cerebrospinal meningitis in East Africa 1911-1965. Transactions of the Royal Society of Tropical Medicine and Hygiene, 65, 70-77.
67. Muraz, G., Chirle, H. & Quéguiner, A. (1938). Essais comparés de traitments (serum, corp azoique, sulfonamide) de la méningite cérébrospinale dans les régions coloniales rurales (Niger français). Presse Médicale, 57, 1113-1116.
68. Olyhoek, T., Crowe, B. A. & Achtman, M. (1987). Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Reviews of Infectious Diseases, 9, 665-692.
69. Ordman, D. (1932). The epidemiology of meningitis in South Africa. South African Medical Journal, 6, 757-765.
70. Park, M. (1907). Travels of Mungo Park, Miller, R. (editor). London: Dent and Sons.
71. Patterson, K. D. & Hartwig, G. W. (1984). Cerebrospinal Meningitis in West Africa and Sudan in the Twentieth Century. Los Angeles: Crossroads Press.
72. Pécoul, B., Varaine, F., Keita, M., Soga, G., Djibo, A., Soula, G., Abdou, A., Etienne, J. & Rey, M. (1991). Long acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet, 338, 862-866.
73. Puddicombe, J. B., Wali, S. S. & Greenwood, B. M. (1984). A field trial of a single intramuscular injection of long-acting chloramphenicol in the treatment of meningococcal meningitis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 78, 399-403.
74. Reingold, A. L., Broome, C. V., Hightower, A. W., Ajello, G. W., Bolan, G. A., Adamsbaum, C., Jones, E. E., Phillips, C., Tiendsebeogo, H. & Yada, A. (1985). Age-specific differences in duration of clinical protection with meningococcal polysaccharide A vaccine. Lancet, ii, 114-118.
75. Rey, M., Ouedraogo, L., Diop-Mar, I., Danjou, G., Buetter, J., Sow, A. & Acard, J. F. (1975). Traitment de la méningite cérébrospinale épidemique à méningocoque par injection intramusculaire unique de chloramphénicol en suspension huileuse. Afrique Médecine, 14, 615-618.
76. Riding, D. & Corkhill, N. L. (1932). Prophylactic vaccination in epidemic meningitis. Journal of Hygiene, 32, 258-267.
77. Robbins, J. B., Towne, D. W., Gotschlich, E. C. & Schneerson, R. (1997). "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. Lancet, 350, 880-882.
78. Scott, D. L. (1965). Epidemic Disease in Ghana 1901-60. Oxford: Oxford University Press.
79. Shircore, J. O. & Ross, P. H. (1913). Epidemic cerebro-spinal meningitis in Nairobi, British East Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 7, 83-95.
80. Smith, A. W., Bradley, A. K., Wall, R. A., McPherson, B., Secka, A., Dunne, D. T. & Greenwood, B. M. (1988). Sequelae of epidemic meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 312-320.
81. Somers, R. B. U. (1939). M and B 693 in cerebrospinal fever. A review of 143 cases treated under field conditions. Lancet, i, 921-922.
82. Thomson, K. D. B. (1973). Mortality trends of epidemic meningitis in northern areas of Nigeria, 1961-70. Journal of Tropical Medicine and Hygiene, 76, 8-12.
83. Twumasi, P. A., Kumah, S., Leach, A., O'Dempsey, T. J. D., Ceesay, S. J., Todd, J., Broome, C. V., Carlone, G. M., Pais, L. B., Holder, P. K., Plikaytis, B. D. & Greenwood, B. M. (1995). A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. Journal of Infectious Diseases, 171, 632-638.
84. Vanderkove, M., Causse, G., Lapeyssonnie, L. & Faucon, R. (1969). Sensibilité aux sulfamides des méningocoques du serotype A. Bulletin of the World Health Organization, 41, 843-850.
85. Varaine, F., Caugant, D. A., Riou, J. Y., Kondé, M. K., Soga, G., Nshimirimana, D., Muhirwa, G., Ott, D., Høiby, E. A., Fermon, F. & Moren, A. (1997). Meningitis outbreaks and vaccination strategy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 3-7.
86. Varaine, F., Keita, M., Kaninda, A.-V. & Habi, G. (1998). Long-acting chloramphenicol versus ceftriaxone for treatment of bacterial meningitis in children aged 2-35 months [Abstract]. 8th International Congress on Infectious Diseases, Boston, USA, 15-18 May.
87. Vieusseux, G. (1806). Memoire sur la maladie qui regné à Geneve au printemps de 1805. Journal de Médecine, de Chirurgie et de Pharmacologie, (Bruxelles), 11, 50-53.
88. Vollum, R. L. & Griffiths, W. W. (1962). An experiment in the prevention of meningococcal meningitis in Nigeria. Journal of Clinical Pathology, 15, 50-53.
89. Waddy, B. B. (1957). African epidemic cerebrospinal meningitis. Journal of Tropical Medicine and Hygiene, 60, 179-189, 218-223.
90. Wahdan, M. H., Rizk, F., El-Akkad, A. M., El Ghoroury, A. A., Hablas, R., Girgis, N. I., Amer, A., Boctar, W., Sippel, J. E., Gotschlich, E. C., Triau, R., Sanborn, W. R. & Cvjetanovic, B. (1973). A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bulletin of the World Health Organization, 48, 667-673.
91. Wahdan, M. H., Sallam, S. A., Hassan, M. N., Abdel Gawad, A., Rakha, A. S., Sippel, J. E., Hablas, R., Sanborn, W. R., Kassem, N. M., Riad, S. M. & Cvjetanovic, B. (1977). A second controlled trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bulletin of the World Health Organization, 55, 645-651.
92. Wali, S. S., Macfarlane, J. T., Weir, W. R. C., Cleland, P. G., Ball, P. A. J., Hassan-King, M., Whittle, H. C. & Greenwood, B. M. (1979). Single injection treatment of meningococcal meningitis. 2. Long-acting chloramphenicol. Transactions of the Royal Society of Tropical Medicine and Hygiene, 73, 698-702.
93. Wall, R. A., Hassan-King, M., Thomas, H. & Greenwood, B. M. (1986). Meningococcal bacteraemia in febrile contacts of patients with meningococcal disease. Lancet, ii, 624.
94. Weichselbaum, A. (1887). Ueber die Aetiologie der akuten Meningitis cerebrospinalis. Fortschritte der Medizin, 5, 573-583.
95. Whittle, H. C., Abdullahi, M. T., Fakunle, F. A., Greenwood, B. M., Bryceson, A. D. M., Parry, E. H. O. & Turk, J. L. (1973a). Allergic complications of meningococcal disease. 1. Clinical aspects. British Medical Journal, ii, 733-737.
96. Whittle, H. C., Davidson, N. McD., Greenwood, B. M., Warrell, D. A., Tomkins, A., Tugwell, P., Zalin, A., Bryceson, A. D. M., Parry, E. H. O., Brueton, M., Duggan, M. & Rajkovic A. D. (1973b). A trial of chloramphenicol for meningitis in northern savannah of Africa. British Medical Journal, iii, 379-381.
97. Whittle, H. C., Tugwell, P., Egler, L. J. & Greenwood, B. M. (1974). Rapid bacterial diagnosis of pyogenic meningitis by latex agglutination. Lancet, ii, 619-621.
98. Whittle, H. C., Evans-Jones, G., Onyewotu, I., Adjukiewicz, A., Turunen, U., Crockford, J. & Greenwood, B. M. (1975). Group C meningococcal meningitis in the northern savannah of Africa. Lancet, i, 1377.
99. WHO (1995). Control of Epidemic Meningococcal Disease. WHO Practical Guidelines. Lyon: Fondation Marcel Mérieux.
100. Williams, E. G. H. & Williams, M. H. (1900). Cerebro-spinal meningitis. Journal of Tropical Medicine, 3, 83-85.
101. Williams, E. G. H. & Williams, M. H. (1901). Cerebro-spinal meningitis. Journal of Tropical Medicine, 4, 22-23.
102. Williamson, W. A. & Greenwood, B. M. (1978). Impairment of the immune response to vaccination after acute malaria. Lancet, i, 1328-1329.